Prevention of Recurrence in Hepatic Encephalopathy

Поділитися
Вставка
  • Опубліковано 29 жов 2024

КОМЕНТАРІ • 3

  • @manoboy3883
    @manoboy3883 4 роки тому

    Very good, thank you

  • @jribe
    @jribe 4 роки тому

    XIFAXAN earned AASLD/EASL's highest possible recommendation (GRADE I,A,1) as an add-on therapy to lactulose to reduce the risk of overt HE recurrence after a patient has a recurrence while on lactulose alone.